The results of the Right Drug, Right Dose, Right Time Using Genomic Data to Individualize Treatment (RIGHT 10K) study provide compelling evidence that proactive testing can benefit almost every patient. Especially when testing goes beyond already known DNA variants.
“Genetic differences can influence how a person processes and responds to medications.” Liwei Wang, MD, director of the Bernard and Edith Waterman Pharmacogenomics Program and director of the Center for Personalized Medicine at Mayo Clinic, says this. “Choosing the right medication to match a person’s genetic makeup can maximize the therapeutic benefit of the drug. But the wrong medicine or the wrong dose can make the medicine ineffective or even fatal.”
